We are live on ! Find out more

2,018 hedge funds and large institutions have $120B invested in Merck in 2018 Q2 according to their latest regulatory filings, with 120 funds opening new positions, 780 increasing their positions, 868 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 77

37% more funds holding in top 10

Funds holding in top 10: 84115 (+31)

10% more call options, than puts

Call options by funds: $1.22B | Put options by funds: $1.1B

10% more capital invested

Capital invested by funds: $110B → $120B (+$10.7B)

1% more funds holding

Funds holding: 1,9932,018 (+25)

0.83% less ownership

Funds ownership: 78.21%77.38% (-0.83%)

10% less repeat investments, than reductions

Existing positions increased: 780 | Existing positions reduced: 868

Holders
2,018
Holders Change
+25
Holders Change %
+1.25%
% of All Funds
46.19%
Holding in Top 10
115
Holding in Top 10 Change
+31
Holding in Top 10 Change %
+36.9%
% of All Funds
2.63%
New
120
Increased
780
Reduced
868
Closed
77
Calls
$1.22B
Puts
$1.1B
Net Calls
+$112M
Net Calls Change
-$116M
Name Holding Trade Value Shares
Change
Change in
Stake
DAM
1601
Deltec Asset Management
New York
$421K -$792K -14,043 -66%
BOS
1602
Bank of Stockton
California
$419K
CCA
1603
Conestoga Capital Advisors
Pennsylvania
$419K
FDCC
1604
Foster Dykema Cabot & Co
Massachusetts
$414K -$3.88M -68,862 -91%
RWA
1605
River Wealth Advisors
Pennsylvania
$414K -$55.8K -989 -12%
PWMAG
1606
Pinnacle Wealth Management Advisory Group
New Jersey
$414K +$13.6K +241 +3%
MSR
1607
Main Street Research
Connecticut
$412K -$15.9K -282 -4%
LA
1608
LexAurum Advisors
Kansas
$411K +$14.8K +262 +4%
AEPG
1609
American Economic Planning Group
New Jersey
$409K -$4.12K -73 -1%
KLI
1610
Kelman-Lazarov Inc
Tennessee
$409K +$1.13K +20 +0.3%
STA
1611
Summit Trail Advisors
New York
$408K -$981K -17,387 -71%
TAM
1612
Taurus Asset Management
New York
$407K +$54.4K +964 +16%
PP
1613
PagnatoKarp Partners
Virginia
$406K -$39.2K -695 -9%
BLAM
1614
Bourne Lent Asset Management
New York
$405K +$4.74K +84 +1%
VCM
1615
Vigilant Capital Management
Maine
$404K -$2.99K -53 -0.8%
PIA
1616
Pinion Investment Advisors
Kansas
$403K +$32.6K +578 +9%
SL
1617
Signition LP
New York
$402K +$391K +6,938 New
SFS
1618
Summit Financial Strategies
Ohio
$401K +$11.9K +211 +3%
HC
1619
Henshaw Capital
Massachusetts
$401K
EWM
1620
Empirical Wealth Management
Washington
$398K +$69.6K +1,233 +22%
OWP
1621
Obermeyer Wealth Partners
Colorado
$396K
KA
1622
Kaizen Advisory
Illinois
$394K +$228K +4,041 +146%
BCA
1623
Berman Capital Advisors
Georgia
$393K +$40.4K +716 +12%
ANBT
1624
American National Bank & Trust
Texas
$392K -$99.7K -1,767 -21%
SAM
1625
SignalPoint Asset Management
Missouri
$392K +$6.66K +118 +2%

MRK Hedge Fund Activity: Q2 2018 in Review

2,018 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2018, worth a combined $120B — up 9.7% from $110B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new MRK positions and 77 closed out — a net gain of 43 holders — while 780 added to existing stakes and 868 trimmed.

The largest buyer was Capital World Investors, adding an estimated $904M. The largest seller was Dodge & Cox, cutting an estimated $620M.

  • 2,018 institutional investors held Merck (MRK) as of Q2 2018, up from 1,993 in Q1 2018.
  • Funds reported $120B of Merck stock for Q2 2018, up 9.7% quarter-over-quarter.
  • 120 funds opened new Merck positions in Q2 2018 and 77 closed out, a net change of +43 holders.
  • The largest Merck buyer in Q2 2018 was Capital World Investors, an estimated $904M added.
  • The largest Merck seller in Q2 2018 was Dodge & Cox, an estimated $620M sold.

Based on aggregated 13F filings for Q2 2018.